GlassScriptPhysician profile
David P Gannon, JR.
NPI 1518966472
$1,935.41
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $497 · 2021: $382 · 2022: $56.35 · 2023: $564 · 2024: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $500 · Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $500.00 |
| Food and Beverage | $195.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrocision, INC. | $500.00 | 2023 | Tenjet |
| Tersera Therapeutics LLC | $238.13 | 2019-2021 | |
| Spr Therapeutics, INC | $174.60 | 2020 | |
| Biodelivery Sciences International, INC. | $155.95 | 2019-2020 | |
| Redhill Biopharma INC. | $142.99 | 2020-2022 | |
| Painteq LLC | $136.58 | 2023-2024 | Painteq |
| Novo Nordisk INC | $97.05 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $85.93 | 2020-2021 | |
| Mdd US Operations, LLC | $48.98 | 2019-2020 | |
| Si-Bone, INC. | $44.08 | 2019 | |
| Lilly USA, LLC | $40.70 | 2021 | |
| Medtronic USA, INC. | $38.92 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $33.62 | 2022 | |
| Pfizer INC. | $30.42 | 2020-2023 | |
| Collegium Pharmaceutical, INC. | $29.10 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $27.22 | 2020 | |
| Depuy Synthes Sales INC. | $23.05 | 2024 | Orthovisc, Monovisc |
| Teva Pharmaceuticals USA, INC. | $22.28 | 2019 | |
| Rayner Intraocular Lenses Limited | $19.90 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Pacira Therapeutics, INC. | $17.64 | 2019 | |
| Ermi LLC | $15.00 | 2021 | |
| Merck Sharp & Dohme LLC | $13.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.